UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹1187 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.81 | 2.25 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 3.03% | 2.73% |
| 6 Month | 13.37% | 20.98% |
| 1 Year | 36.31% | 44.4% |
| 3 Year | 20.52% | 21.78% |
| 5 Year | 27.7% | 27.63% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 25.09% | 39.73% |
| 3 Year | 29.75% | 34.2% |
| 5 Year | 24.61% | 26.11% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 17.79% | 10.93% |
| 3 Year | 20.87% | 15.88% |
| 5 Year | 20.18% | 14.02% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.94% |
| Alpha | 1.57% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 1.53 |
| Large Cap | 45.96 | 32.81 |
| Mid Cap | 27.12 | 26.59 |
| Small Cap | 22.52 | 39.04 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 1.53 |
| Pharmaceuticals & Biotechnology | 75.86 | 75.33 |
| Healthcare Services | 17.38 | 21.22 |
| Retailing | 2.36 | - |
| Healthcare Equipment & Supplies | - | 0.85 |
| Insurance | - | 1.04 |
Top Comparisons
Franklin India Savings Fund - Growth Option
3Y Returns6.38%
Edelweiss Money Market Fund - Regular Plan - Growth Option
3Y Returns5.57%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
3Y Returns22.4%
Quant Healthcare Fund Regular - Growth
3Y Returns0%
SBI Short Term Debt Fund - Regular Plan -Growth
3Y Returns5.86%
LIC MF Short Term Debt Fund Regular - Growth
3Y Returns5.07%
HDFC Infrastructure Fund - Growth Plan
3Y Returns30.22%
Canara Robeco Infrastructure Fund - Regular Plan - Growth Option
3Y Returns28.54%